With each day, COVID-19 seems like it’s not going to go away and we’re going to have to learn to live with this coronavirus. And this just makes us wait endlessly for a vaccine to normalize our lives. While there are some promising vaccines, others have not been so good. But now, according to a study by The Times of Israel, CEO of American pharmaceutical company Pfizer has confirmed we won’t have to wait long.
In case you didn’t remember, Pfizer is actively developing a vaccine in Europe and the US with German pharmaceutical giant BioNTech on a variety of vaccines. Their latest vaccine named ‘BNT162’ undergoes human testing after securing the requisite clinical approvals. The company is evaluating four of its RNA-based vaccines to find out which of the lot is most successful and healthy.
Pfizer’s vaccine is not the only one expected to bring to the shelves this year. The study also revealed the head of UK pharmaceutical giant AstraZeneca. Pascal Soriot said one or more COVID-19 vaccines could begin rolling out early by the end of 2020. AstraZeneca has co-operated with Oxford University and developed a vaccine based on a weakened adenovirus strain. They have combined Adenoviruses which cause common cold in chimpanzees with the novel coronavirus genetic material.
Nonetheless, the US-biotech firm Moderna Inc is leading the vaccine race as of now. Last week, it also cleared stage 1 of its clinical trials. It is all set to begin phase 2 of its trials on 600 healthy people. The vaccine proved effective in developing antibodies to the novel coronavirus.